BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 30078266)

  • 1. [Clinicopathologic and molecular genetic analysis of secretory carcinoma of salivary gland].
    Zhao M; Zhao DH; Cheng G; Yan YJ; Wang Z; He XL
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):533-538. PubMed ID: 30078266
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
    Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
    Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic features of mammary analogue secretory carcinoma of salivary glands].
    Zhang XP; Ni H; Wang X; Chen H; Shi SS; Yu B; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):34-37. PubMed ID: 28072974
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
    Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
    Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.
    Rooper LM; Karantanos T; Ning Y; Bishop JA; Gordon SW; Kang H
    Am J Surg Pathol; 2018 Aug; 42(8):1121-1126. PubMed ID: 29683815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
    Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
    Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E
    J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
    Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
    Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended immunologic and genetic lineage of mammary analogue secretory carcinoma of salivary glands.
    Ni H; Zhang XP; Wang XT; Xia QY; Lv JH; Wang X; Shi SS; Li R; Zhou XJ; Rao Q
    Hum Pathol; 2016 Dec; 58():97-104. PubMed ID: 27658560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
    Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
    Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The screening and electron microscopy observation of mammary analogue secretory carcinoma in Chinese.
    Zhong Y; Liu L; Qi B; Song X; Shen L; Li H
    J Craniomaxillofac Surg; 2018 Jun; 46(6):893-897. PubMed ID: 29752049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.
    Luo W; Lindley SW; Lindley PH; Krempl GA; Seethala RR; Fung KM
    Int J Clin Exp Pathol; 2014; 7(12):9008-22. PubMed ID: 25674280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.
    Skálová A; Weinreb I; Hyrcza M; Simpson RH; Laco J; Agaimy A; Vazmitel M; Majewska H; Vanecek T; Talarčik P; Manajlovic S; Losito SN; Šteiner P; Klimkova A; Michal M
    Am J Surg Pathol; 2015 Mar; 39(3):338-48. PubMed ID: 25581728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
    Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics.
    Luk PP; Selinger CI; Eviston TJ; Lum T; Yu B; O'Toole SA; Clark JR; Gupta R
    Pathology; 2015 Dec; 47(7):659-66. PubMed ID: 26517645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
    Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
    Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.